US Nuclear Corp. (UCLE) research, news, and more from GeoInvesting

Company description

Wed, 12 Jul 2017 14:32:33 GMT

US Nuclear Corp., formerly APEX 3 Inc., provides a range of radiation detection equipment and services. The Company operates through two segments: Optron and Overhoff. Optron is located in Canoga Park, California and Overhoff is located in Milford, Ohio. It designs and manufactures nuclear radiation detection and safety equipment, survey meters, air and water monitors, port security equipment and tritium air monitors. The Company's products consist of radiation water monitors, tritium monitors, air and water monitors, nano-second x-ray monitors, and vehicle, personnel, exit and room monitors. The Company also offers handheld survey meters/dosimeters, and port security equipment, along with supporting software and services. Its two divisions consisting of Optron Scientific Company Inc., doing business as Technical Associates, and Overhoff Technology Corporation (Overhoff) offer over 200 products that service and address the nuclear power industry, domestically and internationally.

Research

Mon, 26 Aug 2019 13:42:17 GMT

Closed Out UCLE Long Position

Us Nuclear Corp (PINK:UCLE) ($0.75; $13.0M market cap) a radiation detection holding company specializing in the development and manufacturing of radiation detection instrumentation was first highlighted by contributor W. Xion in July 2017, you can see his article here.

In early 2018, we issued an alert that we locked in most of our profits in UCLE as shares ran from $0.50 to over $2.00 in a matter of days on no news or filings. We stated we had maintained a small long position.

We have now closed out the remaining portion of our long position. The Company’s financials are just not strong enough for us to hold the shares.

Research

Tue, 20 Nov 2018 16:30:08 GMT

Us Nuclear Corp (PINK:UCLE) ($0.53; $9.1M market cap) - In early 2018, we issued an alert that we locked in most of our profits in UCLE as shares ran from $0.50 to over $2.00 in a matter of days. The company is a radiation detection holding company specializing in the development and manufacturing of radiation detection instrumentation. We stated we had maintained a small long position. Today the Company announced Q3 2018 results:

Sales of $1.14 million vs $0.84 million
Non gaap EPS of $0.00 vs $0.00 in the prior year

“We had a very successful third quarter, with sales revenue up 35.6% for the same period last year” commented Robert I. Goldstein, President, CEO, and Chairman of US Nuclear Corp. “The increase in sales is due to targeted sales efforts and momentum of our signature products, including drinking water monitors, nuclear power plant air and stack monitors, USN/FlyCAM UAV DroneRADs, personnel and vehicle portal monitors, and tritium monitors. We are also incredibly excited about our acquisition of the MIFTEC manufacturing and supply rights, which will start to come to fruition in the near future when MIFTEC and US Nuclear start selling medical isotope generators.”

While we maintained a very small position in the stock, we are not overly confident in management's ability to drive bottom line growth. It also seems management may continue to fund operations via offering stock. Given that we initiated (alerted) our position at $0.29 and locked in most of our profits, we will stick around a little more to see if management can start to deliver meaningful EPS without diluting shareholders too much.

Research

Thu, 22 Feb 2018 15:45:37 GMT

Us Nuclear Corp (PINK:UCLE) ($1,23; $17.1M market cap) a radiation detection holding company specializing in the development and manufacturing of radiation detection instrumentation. In early January 2018 we stated we had locked in nice profits in UCLE as shares ran from $0.50 to over $2.00 in a matter of days. We stated we had maintained a small long position.

Today, the companyannounced that its sales are poised for dramatic growth. “The Company is not only experiencing record high demand for its products, but is also entering the enormous healthcare market with novel solutions for the $10B radioisotope market that is suffering from severe shortages.”

Research

Wed, 10 Jan 2018 19:27:39 GMT

Locked In Some Nice Profits In UCLE

Us Nuclear Corp (PINK:UCLE) ($2.05; $28.5M market cap)

Yesterday we covered UCLE’s recent strong run to $1. Momentum continued in yesterday’s session with shares jumping over $2 a share. We locked in some of the gains from our long position, but still hold a small amount at this time. Shares were trading at around $0.50 last week and have been rocketing this week on no news or filings that we are aware of.

The recent partnership with Miftec to become its official contractor for medical isotope generators in the nuclear medicine market could potentially have been a catalyst for the stock’s performance. The partnership was recently highlighted on Stock News Now.

Research

Tue, 09 Jan 2018 17:00:34 GMT

Us Nuclear Corp (PINK:UCLE) ($1.00; $13.9M market cap), a Run to One Portfolio stock which develops, manufactures, and sells radiation detection and measuring equipment worldwide, saw its shares rocket higher in yesterday’s trading session. Shares were trading at $0.53 at Friday’s close and reached a new high of $1.30 before settling at $1.00 in yesterday’s session.

There was no press release or new filings that we saw. We can only assume the momentum has picked up based on a recent partnership with Miftec to become its official contractor for medical isotope generators in the nuclear medicine market.

The partnership was recently highlighted on Stock News Now, the full video can be seen here.

In July 2017, GeoContributor W. Xion provided an opening look at U.S. Nuclear Corporation in a research note published on the Geo’s Pro Portal. Xion concludes that U.S. Nuclear is “an interesting company with some attractive industry and regulatory trends as tailwinds”. The stock was trading near $0.30 at that time at the time of his column.

Research

Mon, 16 Oct 2017 14:53:18 GMT

UCLE ($0.25), a Run to One Portfolio stock which develops, manufactures, and sells radiation detection and measuring equipment worldwide, announced its first shipment of tritium monitors to the U.S. Air Force. Quotes from management:

"We are very eager and excited to make our first shipment of tritium monitors for the USAF," remarked Robert Goldstein, President and CEO of US Nuclear Corp. "This order represents a sizeable quantity for us, but we were able to smoothly accommodate the large quantity due to our organized quality management system. We successfully allocated our production schedule so that we can steadily produce 15 units to be shipped every month, while simultaneously completing all other current jobs on the backlog. The prepaid partial shipments every month will continue to produce a steady stream of cashflow for a strong finish in 2017."

In July 2017, GeoContributor W. Xion provided anopening look at U.S. Nuclear Corporation in an introductory research note published on the Geo’s Pro Portal. Xion concludes that U.S. Nuclear is “is an interesting company with some attractive industry and regulatory trends as tailwinds”.

Research

Fri, 25 Aug 2017 14:49:39 GMT

UCLE ($0.25) - Shares of UCLE have been under a bit a pressure after reporting sub par Q 2017 results on August 11, 2017 via its 10-Q.

Sales of $491,436 vs $645,523 in the prior year
Loss of $0.01 vs EPS of $0.01 in the prior year

However, on August 23, 2017 the Company issued a press release with slightly more commentary than the 10-Q, showing that it has captured momentum heading into the second half of the year:

“While sales revenue was less than the same period the previous year, we captured important sales opportunities to add to our backlog, while working on finishing production of several substantial quantity orders, which are scheduled to ship in Q3 and Q4. Our cost of sales and operating expenses were higher this period due to the increase in cost of parts required and R&D expenses, but we made excellent progress and will see the results in Q3 and Q4."

The Company is also expanding its product offerings:

“US Nuclear Corp. is also focusing on adding chemical sensors to their DroneRAD product line, with a number of sales already made. Robert remarked, "The successful integration of chemical sensors to our DroneRAD product line, in addition to our radiation sensors, allows us to greatly broaden our market for DroneRAD applications to reach more potential customers with our phenomenal technology."

UCLE remains part of our Micro Cap Run to One Mock Portfolio.

Research

Thu, 27 Jul 2017 15:21:48 GMT

GeoContributor W. Xion on UCLE ($0.30)

GeoContributor W. Xion has provided an opening look at U.S. Nuclear Corporation in an overview research note published on the Geo’s Pro Portal. Xion concludes that U.S. Nuclear is “is an interesting company with some attractive industry and regulatory trends as tailwinds”. In his note, he explores both positive and negative potential catalysts for the company over the next few years. We continue to look into the story but are concerned with the company’s inability to generate consistent recurring revenue. We will update members as our research continues.

See the full content here.

On July 14, 2017 we stated we planned to establish position (which we have since) and added UCLE to our Run to One Mock portfolio.

Research

Fri, 14 Jul 2017 15:20:02 GMT

UCLE ($0.29)

Speaking of run to one, we are adding UCLE to our Run to One Portfolio. UCLE develops, manufactures, and sells radiation detection and measuring equipment worldwide. We had the opportunity to speak with the Company’s management at the LD Micro Cap conference in late June. After this, GeoTeam analyst Siggy Eggert met with them during a July 2017 Micro Cap conference in China.

The company initially entered our radar on strong Q1 2017 results. On May 19, 2017 they reported:

$725,472 vs $252,502 in the prior year
EPS of $0.01 vs loss of $0.01

Quotes from management:

"We are thrilled about our first quarter performance in 2017," commented Robert I. Goldstein, President, CEO, and Chairman of US Nuclear Corp. "We had a very productive start to the year, shipping several large orders that were on our backlog, while simultaneously capturing more sales to carry the momentum forward into the second quarter and position ourselves for an excellent year. We continued to see increasing demand for our DroneRAD product line, with several units currently in production and interest growing daily."

We are still in our early stages of due diligence process, but are intrigued by the results and comments from Q1.